N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine

CAS: 103974-29-4

Ref. 3D-FA17174

Produktinformation

• Name: N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine
• Synonyme: S-(N-Methylcarbamoyl)-N-acetylcysteine, (2R)-2-Acetamido-3-[(methylcarbamoyl)sulfanyl]propanoic acid, (R)-2-Acetamido-3-((methylcarbamoyl)thio)propanoic acid, <span class="text-smallcaps">L</span>-Cysteine, N-acetyl-, methylcarbamate (ester), <span class="text-smallcaps">L</span>-Cysteine, N-acetyl-S-[(methylamino)carbonyl]-, N-Acetyl-S-(N-methylcarbamoyl)cysteine, N-Acetyl-S-[(methylamino)carbonyl]-<span class="text-smallcaps">L</span>-cysteine, N-acetyl-S-(methylcarbamoyl)-L-cysteine, N-acetyl-S-(methylcarbamoyl)cysteine, L-Cysteine, N-acetyl-, methylcarbamate (ester), L-Cysteine, N-acetyl-S-[(methylamino)carbonyl]-, N-Acetyl-S-[(methylamino)carbonyl]-L-cysteine

Beschreibung

N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine is a potent inhibitor of receptor binding. It inhibits the activity of cyclooxygenase and 5-lipoxygenase, which are enzymes that produce inflammatory prostaglandins and leukotrienes. N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine has been shown to inhibit skin cancer cells in a multicenter phase II trial. The compound was detected in urine samples and showed a linear calibration curve with signal detection at concentrations as low as 0.1 ng/mL. The compound also inhibited the growth of human leukemia cells and decreased the level of acidic phospholipids in human erythrocytes. N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine can be used to prevent sample preparation from interfering with subsequent analysis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 220.25 g/mol
• Formel: C₇H₁₂N₂O₄S
• Reinheit: Min. 95%
• InChl: InChI=1S/C7H12N2O4S/c1-4(10)9-5(6(11)12)3-14-7(13)8-2/h5H,3H2,1-2H3,(H,8,13)(H,9,10)(H,11,12)/t5-/m0/s1
• InChI Key: InChIKey=MXRPNYMMDLFYDL-YFKPBYRVSA-N
• SMILES: CNC(=O)SC[C@H](NC(C)=O)C(=O)O